Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: February 26, 2013
Reporting Period: Fourth Quarter and Full Year 2012
This filing announces the issuance of an Investor News release containing the Company's earnings results for the fourth quarter and the twelve months ended December 31, 2012. The detailed financial data is contained in Exhibit 99.1, which is referenced but not fully reproduced in the text of this Form 6-K.
Key Financial Metrics
The text of this Form 6-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It serves as a cover document referencing the attached Investor News (Exhibit 99.1) for these figures.
Non-GAAP Measures Referenced: The filing notes that the attached Investor News includes the following non-GAAP measures to supplement GAAP results:
- EBITDA: Operating income excluding interest, taxes, depreciation, and amortization.
- Free Cash Flow: Defined as a measure of cash flows.
Reconciliations between these non-GAAP measures and the most comparable GAAP measures are stated to be included in the attached Investor News and the Cash Flow Statement.
Material Changes
The filing text does not contain specific data regarding material changes versus prior comparable periods. Investors must refer to the attached Investor News (Exhibit 99.1) for year-over-year comparisons and trend analysis.
Guidance, Outlook, and Risks
Management Commentary: Management states that the inclusion of non-GAAP measures is intended to enhance the user's understanding of current financial performance and future prospects, as well as to provide consistency with prior reporting periods.
Regulatory Disclaimer: The filing explicitly states that the attached Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It also notes that the exhibit is not incorporated by reference into other filings.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this Form 6-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor News) for specific Q4 and Full Year 2012 revenue, net income, and EBITDA figures.
- Verify the reconciliation of non-GAAP measures (EBITDA and Free Cash Flow) to GAAP measures as described in the attached exhibit.
- Confirm the specific year-over-year growth rates and margin changes which are not present in this summary text.
- Check the Cash Flow Statement within the attached exhibit for detailed liquidity and debt servicing data.